Received Jul 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | 2 | UNK | — |
Late Dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a adult female patient who did not receive Men B NVS (Bexsero) for prophylaxis. Previously administered products included Bexsero (1st dose received on 06-MAR-2024). On an unknown date, the patient did not receive the 2nd dose of Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patient experienced incomplete course of vaccination (Verbatim: Late Dose). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 23-JUN-2025 The reporter have a patient came for her second dose but were just informed that the patient was in her first trimester or 8 weeks pregnant and just wanted to get clarification that it was ok to give that vaccine. The vaccine was not administered during pregnancy. Till the time of reporting the patient had not received the second dose of Bexsero, which led to incomplete course of vaccination.